These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 7043035

  • 1. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L.
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [Abstract] [Full Text] [Related]

  • 2. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR.
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U, Dubois M.
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [Abstract] [Full Text] [Related]

  • 6. Oral contraceptives.
    Shearman RP.
    Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
    [Abstract] [Full Text] [Related]

  • 7. [Oral contraception: failures and risks].
    Foussard-blanpin O, Paillot-renaud P, Bruneau-bigot A.
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW.
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [Abstract] [Full Text] [Related]

  • 10. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 11. [Pros and cons of triphasic oral contraception].
    Berdah J.
    Contracept Fertil Sex (Paris); 1985 Dec; 13(12):1205-10. PubMed ID: 12267512
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [How to choose an oral contraceptive in 1984].
    Rozenbaum H.
    Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
    [Abstract] [Full Text] [Related]

  • 15. Low-dose oral contraceptives: progestin potency, androgenicity, and atherogenic potential.
    Ellis J.
    Clin Ther; 1986 Nov; 8(6):607-18. PubMed ID: 3539347
    [Abstract] [Full Text] [Related]

  • 16. [Combined contraceptives and cardiovascular risk].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [Abstract] [Full Text] [Related]

  • 17. Clinical use of biphasic and triphasic pills.
    Cohen J.
    IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
    [Abstract] [Full Text] [Related]

  • 18. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [Abstract] [Full Text] [Related]

  • 19. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG.
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [Abstract] [Full Text] [Related]

  • 20. [Metabolic risks of oral contraception].
    Monier L.
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.